Preventicus offers full service integrated care programs for screening, diagnosis, and management of cardiovascular diseases, such as atrial fibrillation (AF). Preventicus’ unique managed care program has shown to identify and diagnose patients with previously unknown AF in a cost-effective manner that allows to reduce the overall costs linked to stroke.
Distinctive features of Preventicus are superior biosignal-analytic algorithms – certified as a CE class IIa medical product, with worldwide unrivalled clinical evidence – enabling risk screening by smartphone (via App “Preventicus Heartbeats”) or wearables (“Preventicus Nightwatch”). These state-of-the-art medical technologies are embedded in comprehensive managed care programs, including telemedical services (“Telecare”) as well as an intelligent IT ecosystem (“Caresafe” and “Carenet”) for health insurers and providers. Outstanding features of the Preventicus care management programs are the completely digital structures and the pseudonymized concept with a maximum of data protection and data economy.
Company’s Keywords:
atrial fibrillation screening, stroke prevention, cardiac monitoring, atrial fibrillation confirmation, population health management, telemedical service, digital health
<0
<
<2020